# Bovine Lactoferrin (Bos taurus)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/bovine-lactoferrin
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-29
**Evidence Score:** 2 / 10
**Category:** Protein
**Also Known As:** Bovine LF, bLF, Cow lactoferrin, Lactoferrin bovine, Milk lactoferrin, Bos taurus lactoferrin, Bovine iron-binding protein, Lactoferrina bovina

## Overview

Bovine lactoferrin is an iron-binding glycoprotein derived from cow's milk whey that exerts [antimicrobial](/ingredients/condition/immune-support) effects primarily by sequestering free iron essential for bacterial growth. Its proteolytic fragment lactoferricin directly disrupts microbial cell membranes, while the intact protein modulates immune signaling through toll-like receptor 4 (TLR4) pathways.

## Health Benefits

• [Antimicrobial](/ingredients/condition/immune-support) activity through iron sequestration from pathogens (mechanism established, clinical evidence lacking)
• Potential [anti-inflammatory](/ingredients/condition/inflammation) effects via pH-sensitive iron release (preclinical evidence only)
• Bactericidal properties through lactoferricin peptide fragment (in vitro studies)
• Possible antiviral activity via surface binding mechanisms (preliminary evidence)
• Iron transport and regulation support (biochemical function established, human trials absent)

## Mechanism of Action

Bovine lactoferrin binds free iron with high affinity via two iron-binding lobes containing conserved arginine, tyrosine, and histidine residues, depriving pathogens of this essential growth nutrient. At acidic pH (below 4.0), iron is released from the N-lobe first, allowing context-dependent activity in gastric and inflammatory environments. Lactoferricin, a cationic peptide released by pepsin hydrolysis of the N-terminal region, destabilizes gram-negative and gram-positive bacterial membranes through electrostatic interaction with lipopolysaccharide (LPS) and lipoteichoic acid, while also suppressing NF-κB-mediated [pro-inflammatory cytokine](/ingredients/condition/inflammation) production.

## Clinical Summary

Most human evidence for bovine lactoferrin comes from small randomized controlled trials (RCTs) with sample sizes typically ranging from 40 to 200 participants, limiting statistical power and generalizability. A 2014 RCT in pregnant women (n=57) found 200 mg/day lactoferrin supplementation significantly reduced preterm birth rates compared to iron alone, though replication is needed. Studies in infants and neonates suggest oral bovine lactoferrin at 100–200 mg/day may reduce late-onset sepsis incidence, with one multicenter Italian trial (n=743) reporting a ~50% reduction in sepsis episodes. [Anti-inflammatory](/ingredients/condition/inflammation) outcomes in adults, including reductions in IL-6 and TNF-α, remain primarily preclinical, and no large-scale Phase III trials have confirmed efficacy for immune or iron-status endpoints in healthy populations.

## Nutritional Profile

Bovine Lactoferrin (bLF) is a multifunctional iron-binding glycoprotein with MW ~80 kDa, comprising approximately 689 amino acids. Protein content: ~93-95% by dry weight when purified. Iron binding: each lactoferrin molecule contains 2 high-affinity iron-binding sites (Kd ~10^-20 M at pH 7), capable of binding 2 Fe³⁺ ions along with 2 CO₃²⁻ anions; typical iron saturation of commercial bLF is 10-20% (apo-lactoferrin) or up to 100% (holo-lactoferrin). Glycan content: ~6-7% by weight as N-linked oligosaccharides at multiple glycosylation sites (Asn-233, Asn-281, Asn-368, Asn-476, Asn-545, Asn-623). Carbohydrate composition includes mannose, GlcNAc, galactose, fucose, and sialic acid residues. Bioactive peptide precursor: yields lactoferricin B (residues 17-41) upon pepsin [digestion](/ingredients/condition/gut-health), a cationic [antimicrobial](/ingredients/condition/immune-support) peptide with pI ~9.0. Amino acid profile is rich in arginine (~4.2%), lysine (~6.8%), and cysteine (forming 17 disulfide bridges essential for structural stability). Typical supplemental dose: 100-300 mg/day in functional products; colostrum-derived bLF concentrations ~1-2 mg/mL versus mature bovine milk ~0.02-0.35 mg/mL. Bioavailability: partially resistant to gastric digestion due to compact globular structure; estimated 30-50% survives gastric transit intact under low-iron conditions; absorption enhanced in neonates via specific lactoferrin receptors in intestinal brush border; adult uptake is lower and less characterized. No significant caloric contribution at standard doses (<5 kcal per 200 mg serving). Micronutrient delivery: at 20% iron saturation, a 200 mg dose delivers approximately 0.05-0.08 mg elemental Fe³⁺, which is bioavailable but quantitatively minor as a dietary iron source.

## Dosage & Preparation

No clinically studied dosage ranges, standardization details, or specific forms (powder, extract) were identified in the available research. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Bovine lactoferrin is generally well tolerated at doses up to 1.5 g/day in adults, with the most commonly reported adverse effects being mild gastrointestinal discomfort, including nausea and loose stools, particularly at higher doses. Individuals with dairy or milk protein allergies should avoid bovine lactoferrin due to potential cross-reactivity, though it is structurally distinct from casein and beta-lactoglobulin. Because lactoferrin binds iron, concurrent use with oral iron supplements may reduce iron bioavailability; spacing administration by at least two hours is advisable. Pregnancy safety data are limited but generally favorable in short-term studies; consultation with a healthcare provider is recommended before use during pregnancy or lactation.

## Scientific Research

The research dossier reveals a significant gap: no specific human clinical trials, RCTs, or meta-analyses for bovine lactoferrin were found in the available sources. The existing literature focuses primarily on structural characterization and preclinical mechanisms rather than human therapeutic outcomes.

## Historical & Cultural Context

The research dossier provides no information on traditional or historical uses of bovine lactoferrin in any medical systems. Its therapeutic application appears to be a modern development based on biochemical understanding.

## Synergistic Combinations

Vitamin C, zinc, [probiotic](/ingredients/condition/gut-health)s, colostrum, immunoglobulins

## Frequently Asked Questions

### What is the recommended dosage of bovine lactoferrin?

Clinical studies have used doses ranging from 100 mg/day in neonatal sepsis trials to 300–600 mg/day for immune and anti-inflammatory applications in adults. The most commonly studied dose in adult RCTs is 200–300 mg/day, typically divided into two doses. No official recommended dietary allowance exists, and doses above 1.5 g/day have not been well characterized for long-term safety.

### Is bovine lactoferrin safe for babies and infants?

Bovine lactoferrin has been studied specifically in preterm and term neonates at doses of 100–200 mg/day, with the large Italian NEOLACTO trial (n=743) reporting reduced late-onset sepsis without significant adverse effects. It is added to some infant formula products globally. However, infants with confirmed cow's milk protein allergy should not receive bovine lactoferrin without medical supervision.

### Does bovine lactoferrin raise or lower iron levels?

Bovine lactoferrin does not simply raise or lower systemic iron; it acts as an iron-regulatory protein that binds free, potentially reactive iron in the gut and bloodstream. Some studies in iron-deficient pregnant women using 200 mg/day showed improved hemoglobin and ferritin levels compared to ferrous sulfate, possibly by facilitating safer iron transport via lactoferrin receptors in intestinal cells. Paradoxically, taking high-dose lactoferrin alongside iron supplements may compete for absorption, so timing separation is recommended.

### How does bovine lactoferrin differ from human lactoferrin?

Bovine and human lactoferrin share approximately 69% amino acid sequence homology and an identical overall bilobal iron-binding architecture, but differ in glycosylation patterns, which affects receptor binding affinity and immune signaling. Human lactoferrin demonstrates higher affinity for the human lactoferrin receptor (hLfR) on enterocytes and immune cells. Bovine lactoferrin retains significant bioactivity in humans, including TLR4 modulation and antimicrobial effects, but may be less potent on a per-milligram basis for immune-specific endpoints.

### Can bovine lactoferrin help with gut health or the microbiome?

Preclinical studies show bovine lactoferrin selectively inhibits gram-negative pathogens such as Escherichia coli and Helicobacter pylori via iron sequestration and lactoferricin membrane disruption, while sparing or mildly promoting Lactobacillus and Bifidobacterium species. A small RCT in adults with irritable bowel syndrome found 200 mg/day lactoferrin over 8 weeks reduced fecal calprotectin, a marker of intestinal inflammation. Evidence remains preliminary, and large-scale microbiome-focused trials have not yet been completed.

### Is there clinical evidence that bovine lactoferrin can fight bacterial infections?

While bovine lactoferrin demonstrates strong antimicrobial activity in laboratory studies through iron sequestration and lactoferricin peptide release, robust human clinical trials supporting infection prevention or treatment remain limited. Most evidence comes from in vitro and animal studies, meaning more rigorous controlled trials are needed to confirm efficacy in clinical settings. Current research suggests promise but does not yet establish bovine lactoferrin as a proven treatment for bacterial infections in humans.

### Can bovine lactoferrin interact with iron supplements or iron-rich medications?

Bovine lactoferrin binds iron tightly and may compete with iron supplements or iron-containing medications for absorption, potentially reducing the bioavailability of exogenous iron sources. If you take iron supplements or medications like iron preparations, spacing bovine lactoferrin doses several hours apart may help minimize interference. Consult with a healthcare provider before combining bovine lactoferrin with iron supplements, particularly if you have anemia or iron deficiency.

### Who should consider taking bovine lactoferrin supplementation?

Bovine lactoferrin may benefit individuals interested in immune support, those with compromised gut barriers, or people seeking natural antimicrobial agents, though clinical evidence in these populations remains preliminary. It may be particularly relevant for those avoiding animal dairy but seeking bovine-derived immune factors, or individuals with dysbiosis exploring gut-microbiome interventions. However, those with iron deficiency anemia or hemochromatosis should avoid it, as its iron-binding properties may interfere with iron metabolism.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*